MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
Eterna Therapeutics Inc. (NASDAQ: ERNA), formerly, Brooklyn ImmunoTherapeutics, Inc. (BTX)*
Organization & Developments: Eterna Therapeutics
Parents
Eterna Therapeutics Inc. (NASDAQ: ERNA), formerly, Brooklyn ImmunoTherapeutics, Inc. (BTX)*
Children
Brooklyn ImmunoTherapeutics is a clinical stage biopharmaceutical company committed to developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells.
Jumps
Finance & Acquisitions: Eterna Therapeutics
Key People: Eterna Therapeutics